Reported on October 21st, according to the documents disclosed by the Hong Kong Stock Exchange on October 21st, FIL Limited increased its shareholding on October 15th at an average price of 4.1273 Hong Kong dollars per share.$CR MEDICAL (01515.HK)$The company purchased 0.849 million shares of common stock, worth approximately 3.5041 million Hong Kong dollars. After the increase in shareholding, FIL Limited's latest number of shares held is 78.5035 million shares, and the holding ratio has increased from 5.99% to 6.05%.
Other related parties involved in this trade are Pandanus Associates Inc. and Pandanus Partners L.P.
What is equity disclosure?
According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.
Why is equity disclosure important?
Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.
